Breaking News

Inovio Appoints Quality VP

April 1, 2014

Brandreth to head quality and compliance functions for clinical trials

E.J. Brandreth has been appointed vice president of Quality at Inovio Pharmaceuticals, Inc. Mr. Brandreth will be responsible for all quality and compliance functions for clinical trials and scaling up manufacturing and other operations to support the company’s pipeline of immunotherapies and DNA vaccines. He reports to Inovio's chief operating officer, Dr. Niranjan Sardesai.
 
Prior to joining Inovio, Mr. Brandreth had a successful career transitioning start-up clinical biotech operations into commercial entities, and supported the growth of several pharma companies in quality and compliance areas. Most recently, he served as senior vice president of Quality and Regulatory Affairs at Ajinomoto Althea, and previously held similar positions with IDEC, BioMarin and Favrille, Inc.

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important